The knockout of CHI3L1 significantly reduces lipid accumulation and improves insulin resistance in NAFLD through the pAKT/pGSK-3β (pERK) signaling pathway.136. The gene discussed is CHI3L1; the disease is metabolic dysfunction-associated steatotic liver disease.